Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berenbaum

Showing results (641-650 of 805) with videos related to

Pageof 81
Sort By:
Annals of the Rheumatic Diseases|April 3, 2020
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up periodFrancis Berenbaum, Francisco J Blanco, Ali Guermazi, et al.
Addictive Behaviors|February 12, 2013
Changes in alcohol-related brain networks across the first year of college: a prospective pilot study using fMRI effective connectivity mappingAdriene M Beltz, Kathleen M Gates, Anna S Engels, et al.
International Journal of Molecular Sciences|February 26, 2022
Gremlin-1 and BMP-4 Overexpressed in Osteoarthritis Drive an Osteochondral-Remodeling Program in Osteoblasts and Hypertrophic ChondrocytesMaria-Luisa Pérez-Lozano, Laure Sudre, Sandy van Eegher, et al.
Annals of the Rheumatic Diseases|March 17, 2017
Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritisFlorent Eymard, Audrey Pigenet, Danièle Citadelle, et al.
Osteoarthritis and Cartilage|March 17, 2023
Serum carboxymethyllysine concentration is associated with erosive hand osteoarthritisA Cambon-Binder, S Jaisson, S Tuffet, et al.
Annals of the Rheumatic Diseases|March 17, 2004
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxibH Tannenbaum, F Berenbaum, J-Y Reginster, et al.
Joint Bone Spine|May 31, 2020
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
Clinical Rheumatology|June 28, 2018
Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritisLaure Gossec, Francis Berenbaum, Pierre Chauvin, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Annals of the Rheumatic Diseases|November 6, 2017
Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaireLaure Gossec, Pierre Chauvin, Alain Saraux, et al.
Pageof 81

Showing results (641-650 of 805) with videos related to

Sort By:
Pageof 81
Annals of the Rheumatic Diseases|April 3, 2020
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up periodFrancis Berenbaum, Francisco J Blanco, Ali Guermazi, et al.
Addictive Behaviors|February 12, 2013
Changes in alcohol-related brain networks across the first year of college: a prospective pilot study using fMRI effective connectivity mappingAdriene M Beltz, Kathleen M Gates, Anna S Engels, et al.
International Journal of Molecular Sciences|February 26, 2022
Gremlin-1 and BMP-4 Overexpressed in Osteoarthritis Drive an Osteochondral-Remodeling Program in Osteoblasts and Hypertrophic ChondrocytesMaria-Luisa Pérez-Lozano, Laure Sudre, Sandy van Eegher, et al.
Annals of the Rheumatic Diseases|March 17, 2017
Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritisFlorent Eymard, Audrey Pigenet, Danièle Citadelle, et al.
Osteoarthritis and Cartilage|March 17, 2023
Serum carboxymethyllysine concentration is associated with erosive hand osteoarthritisA Cambon-Binder, S Jaisson, S Tuffet, et al.
Annals of the Rheumatic Diseases|March 17, 2004
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxibH Tannenbaum, F Berenbaum, J-Y Reginster, et al.
Joint Bone Spine|May 31, 2020
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
Clinical Rheumatology|June 28, 2018
Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritisLaure Gossec, Francis Berenbaum, Pierre Chauvin, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Annals of the Rheumatic Diseases|November 6, 2017
Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaireLaure Gossec, Pierre Chauvin, Alain Saraux, et al.
Pageof 81